3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
13
Oropharyngeal Neoplasms
11
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Mouth Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Urinary Bladder Neoplasms
6
Nasopharyngeal Carcinoma
6
Hypopharyngeal Neoplasms
6
Pancreatic Neoplasms
5
Mesothelioma, Malignant
5
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
4
Medulloblastoma
4
Ganglioneuroblastoma
4
Gallbladder Neoplasms
4
Neuroblastoma
3
Lymphoid Interstitial Pneumonia
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Salivary Gland Neoplasms
2
Paranasal Sinus Neoplasms
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Interventions
Oxaliplatin
27
Fluorouracil
23
Cetuximab
23
Leucovorin
22
Bevacizumab
21
Nivolumab
16
Capecitabine
16
Irinotecan
15
pembrolizumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
encorafenib
8
Folfox protocol
7
trifluridine tipiracil drug combination
6
Ipilimumab
6
Exercise
6
fludarabine
5
cemiplimab
5
Trastuzumab
5
Gemcitabine
5
Cyclophosphamide
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
regorafenib
4
pertuzumab
4
adagrasib
4
Trifluridine
4
Surgical Procedures, Operative
4
Pemetrexed
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
1 year
×
Clear all
No trials found.